{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:54:40Z","timestamp":1791748480512,"version":"4.3.4"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00608","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T04:29:16Z","timestamp":1594268956000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Pre-treatment With Ranibizumab Aggravates PDT Injury and Alleviates Inflammatory Response in Choroid-Retinal Endothelial Cells"],"prefix":"10.3389","volume":"8","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruowen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1158\/0008-5472.CAN-13-00020008-5472.CAN-13-0002","article-title":"Membrane versus soluble isoforms of TNF-alpha exert opposing effects on tumor growth and survival of tumor-associated myeloid cells.","volume":"73","author":"Ardestani","year":"2013","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbcan.2007.07.001","article-title":"Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.","volume":"1776","author":"Buytaert","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1242\/jcs.163774jcs.163774","article-title":"Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy.","volume":"128","author":"Domigan","year":"2015","journal-title":"J. Cell Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1097\/IAE.0000000000000526","article-title":"Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: the fujisan study.","volume":"35","author":"Gomi","year":"2015","journal-title":"Retina"},{"key":"B5","doi-asserted-by":"publisher","first-page":"48.e1","DOI":"10.1016\/j.ajo.2010.02.008S0002-9394(10)00115-7","article-title":"Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.","volume":"150","author":"Gomi","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00417-014-2675-6","article-title":"Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.","volume":"253","author":"Hata","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/eye.2014.222eye2014222","article-title":"Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome.","volume":"28","author":"Ho","year":"2014","journal-title":"Eye"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10438-z10.1038\/s41467-019-10438-z","article-title":"Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B.","volume":"10","author":"Hogarth","year":"2019","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1097\/IAE.0b013e318276e096","article-title":"Adjusted retreatment of polypoidal choroidal vasculopathy after combination therapy: results at 3 years.","volume":"33","author":"Jeon","year":"2013","journal-title":"Retina"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2012.09.015S1074-7613(12)00514-6","article-title":"Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome.","volume":"38","author":"Kang","year":"2013","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.182.6.1777","article-title":"Metalloproteinase-mediated release of human Fas ligand.","volume":"182","author":"Kayagaki","year":"1995","journal-title":"J. Exp. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semcdb.2018.01.009","article-title":"Caspase-8 function, and phosphorylation, in cell migration.","volume":"82","author":"Keller","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000330793000330793","article-title":"Two-year results of photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.","volume":"226","author":"Kim","year":"2011","journal-title":"Ophthalmologica"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/251584141983115210.1177_2515841419831152","article-title":"Polypoidal choroidal vasculopathy: a comprehensive clinical update.","volume":"11","author":"Kumar","year":"2019","journal-title":"Ther. Adv. Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/IAE.0b013e31820d3f3f","article-title":"Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.","volume":"31","author":"Lai","year":"2011","journal-title":"Retina"},{"key":"B16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/APO.0b013e31827ff5bc01599573-201301000-00008","article-title":"Asian age-related macular degeneration: current concepts and gaps in knowledge.","volume":"2","author":"Lim","year":"2013","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3892\/ijmm.2019.4244","article-title":"RIP1\/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review).","volume":"44","author":"Liu","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5241941","article-title":"Role of the death receptor and endoplasmic reticulum stress signaling pathways in polyphyllin i-regulated apoptosis of human hepatocellular carcinoma HepG2 cells.","volume":"2018","author":"Luo","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1167\/iovs.18-252152717855","article-title":"RF\/6A chorioretinal cells do not display key endothelial phenotypes.","volume":"59","author":"Makin","year":"2018","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021S1097-2765(14)00831-4","article-title":"RIP3 induces apoptosis independent of pronecrotic kinase activity.","volume":"56","author":"Mandal","year":"2014","journal-title":"Mol. Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"556.e7","DOI":"10.1016\/j.immuni.2018.03.008","article-title":"Fas promotes T Helper 17 cell differentiation and inhibits T Helper 1 cell development by binding and sequestering transcription factor STAT1.","volume":"48","author":"Meyer Zu Horste","year":"2018","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s10103-015-1783-9","article-title":"Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells.","volume":"30","author":"Miki","year":"2015","journal-title":"Lasers Med. Sci."},{"key":"B23","first-page":"577","article-title":"Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.","volume":"61","author":"Mitsiades","year":"2001","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nri3131","article-title":"Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways.","volume":"12","author":"Mocarski","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9462","DOI":"10.1021\/bi0260132","article-title":"The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity.","volume":"41","author":"Mohan","year":"2002","journal-title":"Biochemistry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000323811000323811","article-title":"Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.","volume":"225","author":"Moon","year":"2011","journal-title":"Ophthalmologica"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1101\/gad.223321.11327\/15\/1640","article-title":"RIP3: a molecular switch for necrosis and inflammation.","volume":"27","author":"Moriwaki","year":"2013","journal-title":"Genes Dev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00018-016-2203-410.1007\/s00018-016-2203-4","article-title":"Necroptosis-independent signaling by the RIP kinases in inflammation.","volume":"73","author":"Moriwaki","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":":5767","DOI":"10.1007\/s12035-017-0793-y","article-title":"Cell death pathways: a novel therapeutic approach for neuroscientists.","volume":"55","author":"Morris","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3390\/cancers3022516","article-title":"Cell death pathways in photodynamic therapy of cancer.","volume":"3","author":"Mroz","year":"2011","journal-title":"Cancers"},{"key":"B31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10456-010-9185-x","article-title":"Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane.","volume":"13","author":"Nowak-Sliwinska","year":"2010","journal-title":"Angiogenesis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.celrep.2018.06.042","article-title":"NAD(+) depletion triggers macrophage necroptosis, a cell death pathway exploited by mycobacterium tuberculosis.","volume":"24","author":"Pajuelo","year":"2018","journal-title":"Cell Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/IAE.0b013e318225290f","article-title":"LOC387715\/HTRA1 variants and the response to combined photodynamic therapy with intravitreal bevacizumab for polypoidal choroidal vasculopathy.","volume":"32","author":"Park","year":"2012","journal-title":"Retina"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1097\/IAE.0b013e318236e835","article-title":"Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.","volume":"32","author":"Ricci","year":"2012","journal-title":"Retina"},{"key":"B35","doi-asserted-by":"publisher","first-page":"873.e2","DOI":"10.1016\/j.ajo.2011.09.031S0002-9394(11)00780-X","article-title":"Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.","volume":"153","author":"Sagong","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1097\/IAE.0b013e318236e624","article-title":"Combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.","volume":"32","author":"Saito","year":"2012","journal-title":"Retina"},{"key":"B37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00417-013-2433-1","article-title":"Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.","volume":"252","author":"Saito","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2147\/OPTH.S54578opth-8-235","article-title":"One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.","volume":"8","author":"Sakurai","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"95.e1","DOI":"10.1016\/j.ajo.2013.02.006S0002-9394(13)00133-5","article-title":"Comparisons of outcomes with different intervals between adjunctive ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.","volume":"156","author":"Sato","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","article-title":"Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.","volume":"187","author":"Schneider","year":"1998","journal-title":"J. Exp. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni.3206ni.3206","article-title":"The diverse role of RIP kinases in necroptosis and inflammation.","volume":"16","author":"Silke","year":"2015","journal-title":"Nat. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1074\/jbc.M008363200M008363200","article-title":"Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis.","volume":"276","author":"Slee","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.semcdb.2018.01.001","article-title":"An updated view on the functions of caspases in inflammation and immunity.","volume":"82","author":"Songane","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/php.12424","article-title":"Hiporfin-mediated photodynamic therapy in preclinical treatment of osteosarcoma.","volume":"91","author":"Sun","year":"2015","journal-title":"Photochem. Photobiol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.176cddis2012176","article-title":"Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.","volume":"3","author":"Takahashi","year":"2012","journal-title":"Cell Death Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"68.e1","DOI":"10.1016\/j.ajo.2011.07.001S0002-9394(11)00546-0","article-title":"Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.","volume":"153","author":"Tomita","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imr.12541","article-title":"Caspase-8: regulating life and death.","volume":"277","author":"Tummers","year":"2017","journal-title":"Immunol. Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/cdd.2016.20cdd201620","article-title":"Endothelial cell survival during angiogenesis requires the pro-survival protein MCL1.","volume":"23","author":"Watson","year":"2016","journal-title":"Cell Death Differ."},{"key":"B50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","article-title":"Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians.","volume":"53","author":"Wong","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1S2214-109X(13)70145-10020","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/iae.0b013e31823f992a","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV).","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"B53","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10384-013-0234-z","article-title":"Two-year results of reduced-fluence photodynamic therapy combined with intravitreal ranibizumab for typical age-related macular degeneration and polypoidal choroidal vasculopathy.","volume":"57","author":"Yoshida","year":"2013","journal-title":"Jpn. J. Ophthalmol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2017.133cr2017133","article-title":"Plasma membrane changes during programmed cell deaths.","volume":"28","author":"Zhang","year":"2018","journal-title":"Cell Res."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.308cddis2017308","article-title":"Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction.","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.18240\/ijo.2017.03.14ijo-10-03-413","article-title":"Combined photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy: a 2-year result and systematic review.","volume":"10","author":"Zhao","year":"2017","journal-title":"Int. J. Ophthalmol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00608\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T04:29:19Z","timestamp":1594268959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00608\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":56,"alternative-id":["10.3389\/fcell.2020.00608"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00608","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"article-number":"608"}}